Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Highlighted News

    Results (26)

    New formulation helps RNA vaccines withstand high temperatures

    New formulation helps RNA vaccines withstand high temperatures

    RNA vaccines, which have been proven effective against Covid-19, are now being developed for many other diseases, including cancer. One of the drawbacks to these vaccines is that they require ultracold storage, but researchers from MIT have found a promising way to overcome that limitation.With help from an AI algorithm, the researchers tweaked the formulation surrounding the lipid nanoparticles t
    September 28, 2026
    A new technique could accelerate the development of RNA therapies

    A new technique could accelerate the development of RNA therapies

    RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now come up with a way to produce these particles much more quickly, and with more precise control over their size and shape.This new process, which can be run automatically without any human intervention, could greatly speed up the development of
    September 25, 2026
    A new approach to cancer vaccination yields more powerful T cells

    A new approach to cancer vaccination yields more powerful T cells

    MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines — an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.Most vaccines generate both antibodies and T cells that can target the vaccine antigen by activating antigen-presenting cells, such as dendritic cells. In this study, the researchers boosted the
    May 13, 2026
    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    Particles that enhance mRNA delivery could reduce vaccine dosage and costs

    A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.In studies in mice, the researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune response as mRNA delivered by nanoparticles made with FDA-approved materials, but at around 1/100 the dose.“One of the cha
    November 7, 2025
    Supercharged vaccine could offer strong protection with just one dose

    Supercharged vaccine could offer strong protection with just one dose

    Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants — materials that help stimulate the immune system.In a study of mice, the researchers showed that this approach produced a much wider diversity of antibodies against an HIV antigen, compared to the vaccine given on its
    June 18, 2025
    Particles carrying multiple vaccine doses could reduce the need for follow-up shots

    Particles carrying multiple vaccine doses could reduce the need for follow-up shots

    Around the world, 20 percent of children are not fully immunized, leading to 1.5 million child deaths each year from diseases that are preventable by vaccination. About half of those underimmunized children received at least one vaccine dose but did not complete the vaccination series, while the rest received no vaccines at all.To make it easier for children to receive all of their vaccines, MIT r
    May 15, 2025
    A new vaccine approach could help combat future coronavirus pandemics

    A new vaccine approach could help combat future coronavirus pandemics

    A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that could spill over from animals to humans.In addition to SARS-CoV-2, the virus that causes COVID-19, sarbecoviruses — a subgenus of coronaviruses — include the virus that led to the outbreak of the origi
    January 23, 2025
    A two-dose schedule could make HIV vaccines more effective

    A two-dose schedule could make HIV vaccines more effective

    One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.Several years ago, MIT researchers showed that administering a series of escalating doses of an HIV vaccine over a two-week period could help overcome a part of that challenge by generating larger quantities of neutr
    September 20, 2024
    MIT scientists use a new type of nanoparticle to make vaccines more powerful

    MIT scientists use a new type of nanoparticle to make vaccines more powerful

    Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins. These vaccines often include other molecules called adjuvants, which help to boost the immune system’s response to the protein.Most of these adjuvants consist of aluminum salts or other molecules that provoke a nonspecific immune response. A team of MIT researchers has now sho
    March 6, 2024
    Robert Langer receives Dr. Paul Janssen Award

    Robert Langer receives Dr. Paul Janssen Award

    MIT Institute Professor Robert S. Langer was recently honored with the 2023 Dr. Paul Janssen Award for his groundbreaking work in designing novel drug delivery systems that can deliver medications continuously, precisely, and at controlled rates over extended periods. Langer’s pioneering research into biomedical compounds for drug delivery and tissue engineering has impacted a wide range of medica
    February 13, 2024
    MIT-led team receives funding to pursue new treatments for metabolic disease

    MIT-led team receives funding to pursue new treatments for metabolic disease

    A team of MIT researchers will lead a $65.67 million effort, awarded by the U.S. Advanced Research Projects Agency for Health (ARPA-H), to develop ingestible devices that may one day be used to treat diabetes, obesity, and other conditions through oral delivery of mRNA. Such devices could potentially be deployed for needle-free delivery of mRNA vaccines as well.The five-year project also aims to d
    February 5, 2024
    3 Questions: Darrell Irvine on making HIV vaccines more powerful

    3 Questions: Darrell Irvine on making HIV vaccines more powerful

    An MIT research team led by Professor Darrell Irvine has developed a novel kind of vaccine adjuvant: a nanoparticle that can help to stimulate the immune system to generate a stronger response to a vaccine. These nanoparticles contain saponin, a compound derived from the bark of the Chilean soapbark tree, along with a molecule called MPLA, each of which helps to activate the immune system. The adj
    December 12, 2023
    MIT engineers design more powerful RNA vaccines

    MIT engineers design more powerful RNA vaccines

    RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the vaccines, the researchers showed that they could generate Covid-19 RNA vaccines that produce a stronger immune response, at a lower dose, in mice.Adjuvants are molecules commonly used to increase the immu
    September 7, 2023
    MIT researchers to lead a new center for continuous mRNA manufacturing

    MIT researchers to lead a new center for continuous mRNA manufacturing

    A three-year research program led by faculty at MIT aims to design the world’s first fully integrated, continuous mRNA manufacturing platform, in an $82 million effort funded by the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research.The resulting pilot-scale system is intended to improve society’s ability to respond to future pandemics as well as accelerate the de
    July 13, 2023
    Putting the STING into cancer immunotherapy

    Putting the STING into cancer immunotherapy

    Immune checkpoint blockade therapies have been revolutionary in the treatment of some cancer types, emerging as one of the most promising treatments for diseases such as melanoma, colon cancer, and non-small cell lung cancer.  While in some cases checkpoint blockade therapies elicit a strong immune response that clears tumors, checkpoint inhibitors do not work for all tumor types or all patients.
    May 12, 2023
    Four researchers with MIT ties earn 2023 Schmidt Science Fellowships

    Four researchers with MIT ties earn 2023 Schmidt Science Fellowships

    Four researchers with ties to MIT have been named Schmidt Science Fellows this year. Lillian Chin ’17, SM ’19; Neil Dalvie PD ’22, PhD ’22; Suong Nguyen, and Yirui Zhang SM ’19, PhD ’23 are among the 32 exceptional early-career scientists worldwide chosen to receive the prestigious fellowships.“History provides powerful examples of what happens when scientists are given the freedom to ask big ques
    May 12, 2023
    Vaccine printer could help vaccines reach more people

    Vaccine printer could help vaccines reach more people

    Getting vaccines to people who need them isn’t always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don’t have the necessary infrastructure.MIT researchers have come up with a possible solution to this problem: a mobile vaccine printer that could be scaled up to produce hundreds of vaccine doses in a day. This kind of printer, which can fit on a ta
    April 24, 2023
    Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies

    Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies

    Sanofi will provide $25 million over five years to the lab of MIT Professor Daniel Anderson, to support the lab’s efforts to develop next-generation delivery technology for messenger RNA.Anderson, who is a professor of chemical engineering and a member of the Koch Institute for Integrative Cancer Research and the Institute for Medical Engineering and Science, and others in his lab will use the fun
    April 11, 2023
    2022-23 Takeda Fellows: Leveraging AI to positively impact human health

    2022-23 Takeda Fellows: Leveraging AI to positively impact human health

    The MIT-Takeda Program, a collaboration between MIT’s School of Engineering and Takeda Pharmaceuticals Company, fuels the development and application of artificial intelligence capabilities to benefit human health and drug development. Part of the Abdul Latif Jameel Clinic for Machine Learning in Health, the program coalesces disparate disciplines, merges theory and practical implementation, combi
    January 12, 2023
    Celebrating 20 years of discovery, Picower Institute looks ahead to continuing impact

    Celebrating 20 years of discovery, Picower Institute looks ahead to continuing impact

    If ever there was an event that would seem designed for dwelling on the past, it would be the anniversary celebration of an institute centered on the study of memory, but the first of many insights offered by the 20th Anniversary Exhibition of The Picower Institute for Learning and Memory at MIT Sept. 22 was that memory is all about the future.Ever since University of California at Berkeley psycho
    October 12, 2022
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.